You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 433 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab and chemotherapy in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-04

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
433 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab and chemotherapy in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-04
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to November 2024

AbstractFullPdf
Nov 2021322023
Dec 202158011
Jan 202252010
Feb 20224209
Mar 2022168011
Apr 20228608
May 202278013
Jun 202274018
Jul 20224602
Aug 202212404
Sep 202292013
Oct 20228206
Nov 202210409
Dec 20226204
Jan 20234207
Feb 20235802
Mar 202382011
Apr 202394017
May 202312008
Jun 20237001
Jul 202346014
Aug 20237408
Sep 20236206
Oct 202310007
Nov 202346014
Dec 20236806
Jan 20242006
Feb 20242604
Mar 202452010
Apr 20244605
May 20246803
Jun 20242802
Jul 20243407
Aug 20242605
Sep 20243403
Oct 202434010
Nov 20242805
Total26480302